JP2019501108A5 - - Google Patents

Download PDF

Info

Publication number
JP2019501108A5
JP2019501108A5 JP2018501271A JP2018501271A JP2019501108A5 JP 2019501108 A5 JP2019501108 A5 JP 2019501108A5 JP 2018501271 A JP2018501271 A JP 2018501271A JP 2018501271 A JP2018501271 A JP 2018501271A JP 2019501108 A5 JP2019501108 A5 JP 2019501108A5
Authority
JP
Japan
Prior art keywords
mefp
cancer
map
use according
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018501271A
Other languages
English (en)
Japanese (ja)
Other versions
JP6816098B2 (ja
JP2019501108A (ja
Filing date
Publication date
Priority claimed from PCT/CN2015/087011 external-priority patent/WO2017028025A1/zh
Application filed filed Critical
Publication of JP2019501108A publication Critical patent/JP2019501108A/ja
Publication of JP2019501108A5 publication Critical patent/JP2019501108A5/ja
Application granted granted Critical
Publication of JP6816098B2 publication Critical patent/JP6816098B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018501271A 2015-08-14 2016-08-15 粘膜炎症を抑制するためのイガイ接着タンパク質生成物及びその使用 Active JP6816098B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/CN2015/087011 WO2017028025A1 (zh) 2015-08-14 2015-08-14 贻贝粘蛋白产品及其抑制粘膜炎症的应用
PCT/CN2016/095364 WO2017028777A1 (zh) 2015-08-14 2016-08-15 贻贝粘蛋白产品及其抑制粘膜炎症的应用

Publications (3)

Publication Number Publication Date
JP2019501108A JP2019501108A (ja) 2019-01-17
JP2019501108A5 true JP2019501108A5 (enExample) 2019-09-19
JP6816098B2 JP6816098B2 (ja) 2021-01-20

Family

ID=58050454

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018501271A Active JP6816098B2 (ja) 2015-08-14 2016-08-15 粘膜炎症を抑制するためのイガイ接着タンパク質生成物及びその使用

Country Status (12)

Country Link
US (2) US10485848B2 (enExample)
EP (1) EP3335739B1 (enExample)
JP (1) JP6816098B2 (enExample)
KR (1) KR102708321B1 (enExample)
CN (1) CN108348636B (enExample)
AU (1) AU2016309397B2 (enExample)
CA (1) CA2995549C (enExample)
DK (1) DK3335739T3 (enExample)
MA (1) MA42629A (enExample)
MX (1) MX2018000654A (enExample)
SG (1) SG11201800578YA (enExample)
WO (2) WO2017028025A1 (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG11201800440SA (en) 2015-07-20 2018-02-27 Bengt I Samuelsson Institute Of Life Science Res Mussel adhesive protein product and applications thereof in suppression of skin inflammations
MX2018000335A (es) 2015-07-20 2018-05-22 Bengt I Samuelsson Institute Of Life Science Res Aplicaciones de los productos de la proteina adhesiva del mejillon para el tratamiento y la prevencion de enfermedades relacionadas con la melanina.
WO2017011986A1 (zh) 2015-07-20 2017-01-26 赵兵 一种空气过滤装置
WO2017028025A1 (zh) 2015-08-14 2017-02-23 江阴市本特塞缪森生命科学研究院有限公司 贻贝粘蛋白产品及其抑制粘膜炎症的应用
CN110139662B (zh) * 2017-07-05 2022-03-18 江阴贝瑞森制药有限公司 肽的抗炎用途
MA52794A (fr) * 2018-05-28 2021-04-14 Jiangyin Usun Pharmaceutical Co Ltd Nouvelle utilisation pharmaceutique
WO2020182139A1 (zh) * 2019-03-12 2020-09-17 杭州英健生物科技有限公司 消化道黏膜保护胶
EP4028409A4 (en) * 2019-09-14 2023-10-11 EnliTISA (Shanghai) Pharmaceutical Co., Ltd. NEW PEPTIDES
CN114929726A (zh) * 2019-12-02 2022-08-19 艾缇亚(上海)制药有限公司 新肽及其在炎症治疗中的用途
KR102596264B1 (ko) 2020-11-30 2023-11-01 주식회사 바이오빛 기능성 펩티드가 결합된 생체적합 폴리펩티드를 포함하는 염증 질환의 억제용 조성물
CN114588267A (zh) * 2020-12-04 2022-06-07 江苏恒瑞医药股份有限公司 一种含酰胺类局部麻醉药的药物组合物
CN112695064B (zh) * 2021-02-01 2023-06-16 大连海洋大学 从海洋腹足类黏液中提取的抗肝癌和抗肝纤维化的低聚肽
JP2022172889A (ja) * 2021-05-07 2022-11-17 大和製罐株式会社 吐出容器入り薬液
CN115778926A (zh) * 2023-01-30 2023-03-14 南京天纵易康生物科技股份有限公司 一种含贻贝粘蛋白的可降解唇部护理贴剂及其制备方法
CN118059215B (zh) * 2024-01-23 2024-08-30 海南美安生物医药科技有限公司 一种妇科温敏型原位凝胶及其制备和应用
WO2025195444A1 (en) 2024-03-20 2025-09-25 Enlitisa (Shanghai) Pharmaceutical Co., Ltd. New use of peptides derived from vasoactive intestinal peptide
CN118236471B (zh) * 2024-03-21 2025-08-19 湖南天根乐微君科技有限公司 一种用于改善鼻炎症状和鼻腔清洗的组合物及其制备方法和应用

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5605938A (en) 1991-05-31 1997-02-25 Gliatech, Inc. Methods and compositions for inhibition of cell invasion and fibrosis using dextran sulfate
RU2043109C1 (ru) 1992-03-17 1995-09-10 Маина Александровна Бичурина Способ ингибиции вируса гриппа серотипов а и в
CN1112831A (zh) 1994-05-30 1995-12-06 乌力吉 含蜗牛提取液的长效多功能营养护肤水及其制法
NZ314867A (en) * 1997-05-21 1999-04-29 Mcfarlane Lab New Zealand Ltd Glucosamine and mussel extract compositions for use as anti-inflammatories
WO1999064580A1 (en) 1998-06-10 1999-12-16 Georgia Tech Research Corporation Microneedle devices and methods of manufacture and use thereof
US20020018787A1 (en) 1999-05-21 2002-02-14 Roger V. Kendall Methods and compositions for modulating immune response and for the treatment of inflammatory disease
EP1408999B1 (en) 1999-07-21 2008-03-12 Bomac Research Limited Compositions addressing inflammation and/or degenerative disorders
WO2001012146A1 (en) 1999-08-16 2001-02-22 Playtex Products, Inc. Sunscreen lotion or spray composition
US7074433B2 (en) 2001-03-30 2006-07-11 Council Of Scientific And Industrial Research Process for the cure and control of Diabetes mellitus using natural products from Perna viridis
US6770302B2 (en) 2001-03-30 2004-08-03 Department Of Biotechnology Indian green mussel (Perna viridis) as a source of anti-HIV activity
US6905710B2 (en) 2001-08-31 2005-06-14 Council Of Scientific And Industrial Research Pharmaceutical composition useful for inhibition of osteoclast formation and a process for the extraction of mussel hudrolysate from indian green mussel
US20060275370A1 (en) * 2002-07-25 2006-12-07 Yih-Lin Chung Method and compositions for treatment of epithelial damage
US7704518B2 (en) 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
CA2553775A1 (en) * 2004-01-20 2005-08-11 Richard F. Harty Compositions and methods of treatment for inflammatory diseases
CN101348520B (zh) 2007-12-14 2011-10-12 顾铭 一种使用混合吸附色谱分离纯化贻贝粘蛋白的方法
CN101348518B (zh) 2007-12-14 2011-09-28 顾铭 一种使用羧甲基离子交换色谱纯化贻贝粘蛋白的方法
KR101022884B1 (ko) * 2009-06-12 2011-03-16 주식회사 원바이오젠 약물층을 포함하는 폴리우레탄 폼 드레싱제 및 그 제조방법
CN101585874B (zh) 2009-06-30 2012-08-22 江阴贝瑞森生化技术有限公司 一种使用盐析和透析分离纯化贻贝粘蛋白的方法
JP2012526155A (ja) 2009-08-25 2012-10-25 ポステック アカデミー−インダストリー ファンデーション イガイ接着蛋白質またはその変異体に陰イオン性高分子が含まれたコアセルベート
KR101147847B1 (ko) 2010-06-02 2012-05-24 건국대학교 산학협력단 패류 유래 기능성 펩티드의 분리 정제 방법 및 기능성 펩티드의 용도
CN101991840B (zh) 2010-09-26 2012-09-05 浙江海洋学院 抗前列腺癌贻贝酶解提取物的制备方法及应用
KR101384746B1 (ko) * 2011-08-24 2014-04-14 포항공과대학교 산학협력단 홍합 접착 단백질을 이용한 다양한 기능성 생체분자의 표면 고정화
CN102302417B (zh) 2011-09-13 2012-12-26 佛山市安安美容保健品有限公司 一种含有海洋生物活性物质的全效防晒乳液
WO2013143077A1 (zh) * 2012-03-28 2013-10-03 江阴贝瑞森生化技术有限公司 使用多模式色谱纯化贻贝粘蛋白的方法
WO2014186937A1 (zh) * 2013-05-20 2014-11-27 Gao Min 贻贝粘蛋白凝胶的制备方法、贻贝粘蛋白凝胶及其应用
CN103520766A (zh) * 2013-09-25 2014-01-22 高敏 贻贝粘蛋白液体产品、其制备方法及其应用
CN104323927A (zh) 2014-11-06 2015-02-04 济南星河康泰贸易有限公司 贻贝粘蛋白在制备皮肤美容化妆品上的应用
CN104645313A (zh) * 2015-01-28 2015-05-27 南京航空航天大学 一种修复止痒贻贝粘蛋白凝胶剂及其制备方法
CN104645320A (zh) 2015-01-28 2015-05-27 南京航空航天大学 一种创面修复用贻贝粘蛋白凝胶剂及其制备方法和应用
CN104857552B (zh) 2015-05-18 2018-08-10 赵明 一种止血贴及其制备方法
WO2017011986A1 (zh) 2015-07-20 2017-01-26 赵兵 一种空气过滤装置
SG11201800440SA (en) 2015-07-20 2018-02-27 Bengt I Samuelsson Institute Of Life Science Res Mussel adhesive protein product and applications thereof in suppression of skin inflammations
MX2018000335A (es) 2015-07-20 2018-05-22 Bengt I Samuelsson Institute Of Life Science Res Aplicaciones de los productos de la proteina adhesiva del mejillon para el tratamiento y la prevencion de enfermedades relacionadas con la melanina.
WO2017028025A1 (zh) 2015-08-14 2017-02-23 江阴市本特塞缪森生命科学研究院有限公司 贻贝粘蛋白产品及其抑制粘膜炎症的应用

Similar Documents

Publication Publication Date Title
JP2019501108A5 (enExample)
JP6816098B2 (ja) 粘膜炎症を抑制するためのイガイ接着タンパク質生成物及びその使用
BRPI0820520B8 (pt) processo para a fabricação de formas de dosagem mastigáveis para a liberação de fármacos e produtos dos mesmos
AR108594A2 (es) Formulaciones farmacéuticas que conservan el sabor con características farmacéuticas mejoradas
JP2016175936A5 (enExample)
ATE470443T1 (de) Indol-1-yl-essigsäurederivate
BRPI0608877B8 (pt) composição imunogênica de rotavírus líquida, uso de um antígeno de rotavírus, um açúcar e um carboxilato, e, método para a preparação de uma composição de rotavírus líquida
CN103800906A (zh) 用于刺激哺乳动物对病原体的先天免疫抵抗力的组合物
MX2020005518A (es) Mezclas no racemicas y usos de las mismas.
WO2018234871A3 (en) COMPOSITIONS FOR DRUG DELIVERY AND METHODS OF USE
JP5153948B1 (ja) アレルギー性鼻炎用塗付剤
Zaborova et al. Malasseziosis in athletes
ATE516015T1 (de) Galenische form zur oralen transmukosalen zuführung von triptanen
CN105520944A (zh) 一种稳定的吸入用茶碱乙酸氨溴索溶液
JP2010260855A (ja) 気道異物除去剤及び気道異物除去用組成物
JP2005068089A (ja) コロナウイルス消毒剤
RU2018143557A (ru) Карбоновые кислоты, предназначенные для применения в раннем детстве
MX369760B (es) Composición farmacéutica de citrato de sildenafilo en forma de suspensión para uso oral.
ES2673193B1 (es) Procedimiento de obtención de un producto de tratamiento fungicida y producto obtenido
TH167609A (th) สูตรตำรับพีมีแทรกเซด (pemetrexed) ที่มีความคงตัว
BR112019000282A2 (pt) forma de dosagem oral contendo um revestimento exterior de liberação rápida
NZ732278A (en) Oral rehydration composition and methods thereof
JO2335B1 (en) Fixed pharmaceutical formulations and method of preparation including antibiotic and repellent
HK1257176B (en) Mussel adhesive protein product and the use thereof for the treatment of inflammation of the mucosa
Ahmad et al. Bioadhesive Vaginal Gels of Novel Antimicrobial Combinations from Herbal Sources.